Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
2(50.0%)
Phase 2
1(25.0%)
N/A
1(25.0%)
4Total
Phase 4(2)
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04975269Phase 2Completed

Acetazolamide Trial in Normal Pressure Hydrocephalus

Role: collaborator

NCT05910944Recruiting

European Study of Prodromal iNPH

Role: collaborator

NCT02727517Not ApplicableCompleted

Early or Late Cord Clamping in the Depressed Neonate

Role: collaborator

NCT00906828Phase 4Completed

Pharmacokinetics of Levodopa/Carbidopa Infusion With and Without Oral Catechol-O-methyl Transferase (COMT) Inhibitors

Role: collaborator

NCT00888186Phase 4Completed

Different Dyskinesias in Parkinson's Disease and Their Relation to Levodopa Pharmacokinetics

Role: collaborator

All 5 trials loaded